» Authors » Salyka M Sengsayadeth

Salyka M Sengsayadeth

Explore the profile of Salyka M Sengsayadeth including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 36
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Bhaskar S, Dholaria B, Sengsayadeth S, Savani B, Oluwole O
EJHaem . 2022 Jul; 3(Suppl 1):39-45. PMID: 35844303
Chimeric antigen receptor (CAR) T-cell therapy has been approved for use in several relapsed/refractory hematologic malignancies and has significantly improved outcomes for these diseases. A number of different CAR T...
2.
Sengsayadeth S, Dholaria B, Savani B, Oluwole O
EJHaem . 2022 Jul; 3(Suppl 1):3-5. PMID: 35844302
No abstract available.
3.
Gatwood K, Culos K, Binari L, Engelhardt B, Kassim A, Byrne M, et al.
Bone Marrow Transplant . 2018 Mar; 53(6):795-799. PMID: 29540851
No abstract available.
4.
Sengsayadeth S, Savani B
Expert Rev Hematol . 2013 Sep; 6(4):341-2. PMID: 23991919
No abstract available.
5.
Engelhardt B, Sengsayadeth S, Jagasia M, Savani B, Kassim A, Lu P, et al.
Exp Hematol . 2012 Aug; 40(12):974-982.e1. PMID: 22885125
Regulatory T cells (Tregs) are a subset of CD4(+) T cells that are characterized by the expression of CD25 and Foxp3 and are capable of suppressing alloimmune responses. We assessed...
6.
Sengsayadeth S, Srivastava S, Jagasia M, Savani B
Biol Blood Marrow Transplant . 2012 Mar; 18(10):1479-87. PMID: 22449611
Although allogeneic hematopoietic stem cell transplant (allo-HSCT) is performed to treat otherwise incurable and fatal diseases, transplantation itself can lead to life-threatening complications due to organ damage. Pulmonary complications remain...